Syngene International

Innovation often slows when funding or decisions are still in motion. The mAb Accelerator Program helps teams start early, share risk, and move toward the clinic without waiting for certainty. Learn more: syngeneintl.com/mab-accelerato… #Biologics #mAb #CDMO

#BioconFoundation, with @SyngeneIntl & @AgastyaOrg, organized a mega science fair in Shorapur, Yadgiri. Government school students showcased their curiosity through innovative science models, and vibrant science-themed rangolis added to the celebration of learning. #ScienceForAll

San Francisco, let’s talk biologics. Syngene heads to the American Biomanufacturing Summit, April 14-15. Our biologics CDMO platform delivers speed, scale, and supply chain confidence with GMP manufacturing in the US and India. Book a meeting: go.pardot.com/l/595011/2025-… #Biologics

Got a manufacturing challenge that cannot wait? Syngene team will be at DCAT 2026 to discuss biologics, TIDES, oligos, small molecules, and advanced modalities with our CDMO experts in New York. Book a meeting: go.pardot.com/l/595011/2025-… #DCAT2026 #CDMO #Syngene

What does it take to design better Antibody Drug Conjugates (ADCs)? Dr. Nikhil Jain, Scientific Director at Syngene, will speak at Aarogya Next, IIT Bombay on March 21, unpacking the ABCD of ADCs and a data driven path to next-gen therapeutics. #AarogyaNext #Syngene #Innovation

Texas, we are here! Meet Syngene’s Bioanalytical team at WRIB 2026, April 13–17 in Dallas. We partner from early development to clinical milestones. Stop by Booth #66. Book a meeting: go.pardot.com/l/595011/2025-… #WRIB2026 #Bioanalysis #BioanalyticalScience #DallasTX

Can India shift from the pharmacy of the world to an innovation hub? Pharma Anveshan’26 convened 1,000+ voices from industry, policy & academia. Representing Syngene, Dr. Anand Kulkarni shared how technology can accelerate development & enable complex modalities. #Pharma #India

Syngene is recognized in the CDP Supplier Engagement Assessment Leadership band. This reflects our work to drive sustainability across the value chain by helping suppliers move toward science-based targets and stronger Scope 3 readiness. #Sustainability #ClimateChange #CDP

Early development risks can slow biologics programs. In partnership with BioProcess International, Sunit and Samantha will share practical approaches from cell line development to IND readiness. Register now: bpi.bioprocessintl.com/de-risking-bio… #Biologics #DrugDevelopment #INDReadiness

Proud moment for Syngene! Our Biologics Manufacturing team has received the RBNQA Performance Excellence Trophy 2025, reflecting our focus on quality, strong governance, and continuous improvement. Congrats to the team. #RBNQA #QualityLeadership #Excellence #Biologics

What’s next in cancer drug discovery? Dr. Jayashree Aiyar, CSO at Syngene, delivers an invited talk on multimodal cancer drug discovery at Arogya Next, IIT Bombay, March 21. Join the conversation on next-gen therapeutics. #ArogyaNext #Oncology #DrugDiscovery #Syngene

Progress in healthcare accelerates when science, industry, and policy align. Syngene’s VP of Biologics, Sunit Maity, engaged with NIPER Hajipur advanced dialogue on translating innovation into scalable healthcare impact. #AcademiaIndustry #TranslationalResearch #Syngene

Syngene is gearing up for #SOT2026 in San Diego. We’re excited to engage with the global toxicology community and showcase our end‑to‑end Safety Assessment platform supporting confident, data‑driven IND progression. #SafetyAssessment #Toxicology #DrugDevelopment #Syngene

The future of talent is often shaped where academia meets industry. Prashant Latthe, Director of Chemistry at Syngene, participated in the Industry‑Academia Conclave at Christ University, engaging on research translation and industry‑ready talent. #IndustryAcademia #STEM

Oncology programs move faster with integrated discovery. Syngene brings assay biology, 90+ in vivo models, imaging, PK/PD, biomarkers and IND‑enabling insights under one roof. Meet our team at #AACR2026. Book a meeting: go.pardot.com/l/595011/2025-… #OncologyResearch #DrugDiscovery

Syngene is named an ‘Industry Mover’ in Life Sciences in the S&P Global Sustainability Yearbook 2026, recognising year‑on‑year ESG improvement. Our CSA score rose 55% in one year, reflecting deeper sustainability integration. #IndustryMover #ESGP #Sustainability

As we mark the 55th National Safety Week, teams across India turned commitment into daily practice. From safety oaths to site‑led actions, the focus was clear: engage people, build awareness, & enable safer choices together, every day. #NationalSafetyWeek #SafetyFirst #Syngene

43% of India’s STEM graduates are women, yet few reach leadership. Closing this gap isn’t a social goal, it’s an economic necessity. Retention matters: role models, mentoring, supportive workplaces, clear leadership paths. Read more: bwhealthcareworld.com/article/india-… #WomenInSTEM

Meet us at DCAT. Scale‑up deviations, HPAPI handling and fragmented tech transfers cause costly delays. Syngene addresses this with robust process engineering and compliant cGMP manufacturing built for reliability at scale. Let's connect: go.pardot.com/l/595011/2025-… #CDMO #HPAPI

Syngene Bengaluru achieves ISO 50001:2018 Energy Management certification with a zero non‑conformity Stage 2 audit, strengthening energy governance across the Bengaluru SEZ and accelerating our sustainability journey. Kudos to Engineering & Maintenance. #ISO50001 #ESG #Syngene